AAVantgarde Closes $141m Series B Round to Tackle Inherited Eye DiseasesBeckie Barrett2025-11-27T16:31:14+00:00November 27th, 2025|Investment, News|
Rinri Therapeutics Gets the Green Light to Launch First-in-Human Trial for Rincell-1Amy Cotterill2025-07-15T12:20:21+01:00July 15th, 2025|Article, Investment, News|
AI-Powered Idea Wins Cranfield-Colworth Innovation ChallengeAmy Cotterill2025-03-24T16:21:46+00:00March 24th, 2025|Colworth Park, Investment, News|
Alveron Pharma Announces €5M Seed Extension Financing To Accelerate Breakthrough Therapy For Intracranial HaemorrhageGemma Cann2024-12-09T14:20:07+00:00December 9th, 2024|BioCity Nottingham, Investment|
World-Class ‘Accelerator’ To Speed Development Of Crucial Rehabilitation TechnologiesGemma Cann2024-11-28T15:34:26+00:00November 21st, 2024|Investment, News|
How Pioneer Group’s Golden Ticket Programmes Are Fast-Tracking InnovationBeckie Barrett2024-11-28T14:22:22+00:00October 9th, 2024|Accelerator, Investment, News|
Novo Nordisk Partners With Pioneer Group To Launch The Golden Ticket ProgrammeGemma Cann2024-12-05T10:36:15+00:00September 19th, 2024|Accelerator, Investment, News|
NanoSyrinx Closes c. £10 Million Financing And Appoints Dr Edwin Moses As ChairmanGemma Cann2024-11-28T14:22:38+00:00September 11th, 2024|Investment, News|
What Are The Current Life Sciences Investment Trends?Beckie Barrett2024-08-21T14:19:26+01:00August 21st, 2024|Article, Investment|
MediCity Nottingham: 4D Medicine Raises £3.4m For Unique Biomaterial PlatformGemma Cann2024-11-28T14:22:54+00:00July 26th, 2024|Investment, MediCity Nottingham, News|
